Vanguard Group Inc Biofrontera Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.77 - $24.8 $4,975 - $160,257	6,462 Added 3.04%	219,052 $201,000
Q2 2022 Aug 12, 2022	BUY	$37.2 - $99.2 $2.29 Million - $6.09 Million	61,427 Added 40.64%	212,590 $395,000
Q1 2022 May 13, 2022	SELL	$45.0 - $138.4 $94,950 - $292,024	-2,110 Reduced 1.38%	151,163 $503,000
Q4 2021 Feb 14, 2022	BUY	$49.4 - $263.4 $7.57 Million - $40.4 Million	153,273 New	153,273 $1.15 Million

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $22.6M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.